TAstV-2 ORF1 encodes a 1,638-amino acid polyprotein (UniProt ID: Q9ILI5) with the following features:
Gene structure: Split into ORF1a (N-terminal) and ORF1b (C-terminal), linked by a ribosomal frameshift mechanism .
Domains: Contains conserved motifs for RNA helicase, serine protease, VPg (viral protein genome-linked), and transmembrane regions .
| Domain | Position (AA) | Function |
|---|---|---|
| RNA helicase-like | 1-300 | Putative RNA unwinding activity |
| Serine protease | 450-600 | Polyprotein self-cleavage |
| VPg domain | 700-800 | Genome replication initiation |
| Transmembrane region | 900-1050 | Membrane association of RCs |
The full-length 1AB polyprotein is cleaved into:
p19: N-terminal regulatory protein
Transmembrane protein 1A: Anchors replication complexes (RCs) to ER membranes
Serine protease p27: Mediates polyprotein processing (EC 3.4.21.-)
The protein has been successfully expressed in:
| Region | TAstV-2 vs CAstV | TAstV-2 vs DAstV |
|---|---|---|
| ORF1a | 77.8-99.4 | 50.5-60.9 |
| ORF1b | 86.2-98.1 | 58.4-69.7 |
| ORF2 | <75 | <50 |
Protease inhibitor screening: Used to test compounds targeting the conserved serine protease domain .
Vaccine development: Serves as antigen for monoclonal antibody production (e.g., mouse IgG2a MAbs for lateral flow assays) .
Evolutionary studies: Recombination analysis using ORF1 sequences helps track viral spread in poultry farms .
While recombinant ORF1 polyproteins enable structural studies (cryo-EM efforts ongoing), limitations include:
Instability of full-length constructs requiring co-expression with chaperones .
Lack of robust cell culture systems for TAstV-2, necessitating reverse genetics approaches .
Current research focuses on:
This protein participates in the viral protease cleavage of the polyprotein into functional products. It also encompasses the activities required for genomic RNA replication and subgenomic mRNA transcription. The protein is covalently attached to the 5' end of both genomic and subgenomic RNAs.
Turkey astrovirus 2 Non-structural polyprotein 1AB (ORF1) is a critical component of the viral genome that encodes multiple functional proteins essential for viral replication. The astrovirus genome typically contains three open reading frames (ORFs): ORF1a, ORF1b, and ORF2, with a frameshift structure between ORF1a and ORF1b . ORF1 encodes non-structural proteins including both a protease and an RNA-dependent RNA polymerase.
When processed, the Non-structural polyprotein 1AB is cleaved into multiple functional chains:
The full amino acid sequence contains multiple functional domains that contribute to viral replication, protein processing, and genome synthesis. From a genetic perspective, the ORF1b region of astroviruses appears to be the least divergent among different ORFs, suggesting evolutionary constraints on this functionally critical region .
For optimal experimental outcomes when working with Recombinant Turkey astrovirus 2 Non-structural polyprotein 1AB, researchers should follow these methodological guidelines:
Storage protocols:
Handling procedures:
The protein is typically supplied in a stabilizing Tris-based buffer containing 50% glycerol
When designing experiments, account for buffer components that may affect assay conditions
Upon receipt, divide the protein into small working aliquots to minimize freeze-thaw cycles
Expression considerations:
The recombinant protein can be successfully expressed in bacterial systems such as E. coli
His-tagging is commonly used to facilitate purification, though tag type may vary depending on the production process
When expressing custom constructs, the sequence information available (UniProt: Q9ILI5) can guide design strategies
When selecting an expression system for Recombinant Turkey astrovirus 2 Non-structural polyprotein 1AB, researchers should consider the experimental requirements and protein characteristics:
Bacterial expression systems (E. coli):
Most commonly used for recombinant astrovirus proteins as demonstrated in available products
Advantages: High yield, cost-effectiveness, scalability, rapid production timelines
Limitations: Lacks eukaryotic post-translational modifications, potential for inclusion body formation
Methodology: Optimize codon usage for bacterial expression, consider fusion tags for solubility enhancement, test multiple strains (BL21, Rosetta, etc.)
Insect cell expression systems:
Appropriate when mammalian-like post-translational modifications are required
Advantages: Better protein folding than bacterial systems, moderate cost, good for complex viral proteins
Limitations: Lower yields than bacterial systems, more technical expertise required
Methodology: Baculovirus expression vectors, Sf9 or High Five cells, optimize infection conditions
Mammalian expression systems:
Consider when authentic viral protein processing and folding are critical
Advantages: Native-like protein processing, appropriate for functional studies
Limitations: Highest cost, lowest yields, technically demanding
Methodology: HEK293 or CHO cells, transient or stable expression approaches
The choice of system should be guided by the intended application, with bacterial systems sufficient for antibody production but more complex systems potentially necessary for functional enzymatic studies of the protease or RNA-dependent RNA polymerase domains.
Recombination events in astroviruses, including Turkey astrovirus 2, are important evolutionary mechanisms that contribute to viral diversity and adaptation. The following methodological approaches have proven effective for studying these events:
Comprehensive genomic sequencing and analysis:
Recombination detection algorithms and software:
Strategic phylogenetic analysis:
Construct separate phylogenetic trees for different genomic regions (ORF1a, ORF1b, ORF2)
Incongruent tree topologies suggest recombination events
Maximum-likelihood methods with appropriate nucleotide substitution models (e.g., Tamura-Nei, General Time Reversible) and robust bootstrap support (1000 replicates) are recommended
Targeted analysis of recombination hotspots:
The ORF1b/ORF2 junction represents a preferential site for RNA crossover in astroviruses
Studies have identified five potential recombination sites in the astrovirus genome, with three near the conserved region between ORF1b and ORF2
Primers designed to flank these regions are particularly useful for identifying recombinants
Experimental verification of recombinants:
In vitro recombination assays to test hypotheses about recombination mechanisms
Reverse genetics approaches to create synthetic recombinants and evaluate their viability
Cell culture systems to study the replication efficiency of natural recombinants
Analysis of the serine protease activity within the Non-structural polyprotein 1AB requires specialized biochemical approaches:
Substrate design and cleavage assays:
Design synthetic peptides mimicking natural cleavage sites within the viral polyprotein
Incorporate fluorogenic or chromogenic groups for detection (e.g., pNA, AMC, FRET-based substrates)
Measure cleavage kinetics under varying conditions (pH, temperature, ionic strength)
Methodology: Spectrofluorometric or spectrophotometric monitoring of substrate processing in real-time
Protease domain expression and purification:
Express the serine protease p27 domain (identified in the polyprotein ) in isolation
Compare activity of isolated domain versus the full polyprotein context
Ensure proper folding through activity-based assays
Methodology: Size-exclusion chromatography to confirm monomeric state, circular dichroism to verify secondary structure
Inhibitor profiling and characterization:
Test class-specific protease inhibitors (e.g., PMSF, aprotinin for serine proteases)
Develop targeted inhibitors based on substrate sequences
Perform structure-activity relationship studies with modified inhibitors
Methodology: IC50 determination, inhibition kinetics (competitive, non-competitive, uncompetitive)
Mutagenesis studies:
Identify the catalytic triad through sequence alignment with other viral serine proteases
Create point mutations in putative active site residues
Assess impact on protease activity and polyprotein processing
Methodology: Site-directed mutagenesis, activity comparisons, SDS-PAGE analysis of processing
Structural characterization:
X-ray crystallography or cryo-EM studies of the protease domain
NMR for dynamic analysis of substrate binding
Computational modeling of enzyme-substrate interactions
Methodology: Protein crystallization trials, structural refinement, molecular dynamics simulations
These approaches can help elucidate the mechanism of action of the viral protease and potentially identify targets for antiviral intervention.
The RNA-dependent RNA polymerase (RdRp) encoded within ORF1 presents unique challenges for functional studies:
Key Challenges:
Protein expression and purification obstacles:
Obtaining sufficient quantities of active enzyme
Maintaining structural integrity and enzymatic activity during purification
Determining the minimal functional unit versus requirements for additional viral factors
Enzymatic activity assessment:
Designing appropriate template RNAs that mimic viral genomic elements
Distinguishing between de novo initiation and primer-dependent synthesis
Quantifying activity with sufficient sensitivity and specificity
Evolutionary considerations:
Methodological Strategies:
Protein engineering approaches:
Express the RdRp domain with flanking sequences that may contribute to function
Consider fusion constructs with solubility-enhancing tags
Engineer constructs based on known structures of related viral RdRps
Methodology: Rational construct design, thermal shift assays to optimize buffer conditions
In vitro polymerase assays:
Filter-binding assays with radiolabeled nucleotides
Real-time monitoring of RNA synthesis using fluorescent nucleotide analogs
PAGE analysis of RNA products to assess length and integrity
Methodology: Optimization of reaction conditions (metal ions, pH, temperature)
Template design considerations:
Construct templates containing authentic viral 3' termini
Compare homopolymeric versus virus-specific templates
Evaluate the impact of RNA secondary structures on polymerase activity
Methodology: In vitro transcription of defined templates, RNA folding prediction
Fidelity and error analysis:
Measure nucleotide misincorporation rates
Sequencing of synthesized RNA products to assess error frequencies
Competition assays with correct versus incorrect nucleotides
Methodology: Next-generation sequencing of products, single-nucleotide incorporation kinetics
These approaches can provide insights into the fundamental mechanisms of astrovirus genome replication and the specific adaptations in Turkey astrovirus 2.
Mutations in the Non-structural polyprotein 1AB can significantly impact viral fitness and disease outcomes through various mechanisms:
Understanding the complex effects of mutations requires full genomic analyses and functional studies . The relatively conserved nature of ORF1b across astroviruses suggests functional constraints that can guide the interpretation of naturally occurring or engineered mutations.
Investigating protein-protein interactions involving the Non-structural polyprotein 1AB requires a multi-faceted approach:
In vitro approaches:
Pull-down assays:
Express recombinant polyprotein with affinity tags
Immobilize on appropriate matrix and incubate with potential interaction partners
Identify bound proteins through mass spectrometry or western blotting
Methodology: Optimize binding and washing conditions to minimize non-specific interactions
Surface plasmon resonance (SPR):
Measure real-time binding kinetics and affinities
Quantitative assessment of association and dissociation rates
Evaluate effects of mutations on binding properties
Methodology: Immobilize one protein partner on sensor chip, flow analyte at varying concentrations
Cellular approaches:
Proximity-based labeling techniques:
BioID or TurboID fusion proteins express in relevant cell types
Identify proteins within nanometer-scale proximity to the polyprotein
Mass spectrometry analysis of biotinylated proteins
Methodology: Optimize labeling time, control for background biotinylation
Fluorescence-based interaction assays:
Bimolecular fluorescence complementation (BiFC) to visualize interactions in cells
Förster resonance energy transfer (FRET) for detecting proximal proteins
Fluorescence correlation spectroscopy for dynamic interaction studies
Methodology: Construct design with appropriate linkers, controls for non-specific assembly
Computational and structural approaches:
Molecular docking and simulation:
Predict interaction interfaces between the polyprotein and partners
Molecular dynamics simulations to assess stability of predicted complexes
Evaluation of electrostatic and hydrophobic contributions to binding
Methodology: Homology modeling when structures are unavailable, integration with experimental data
Structural studies of complexes:
Cryo-electron microscopy of purified complexes
X-ray crystallography of co-crystallized proteins
Cross-linking mass spectrometry to identify interaction sites
Methodology: Chemical cross-linkers of various lengths, MS/MS analysis of cross-linked peptides
When studying interactions involving the Non-structural polyprotein 1AB, it's critical to consider both the full polyprotein and its cleaved products, as processing significantly alters interaction potential. Additionally, viral replication complex formation may require multiple viral and host proteins, necessitating more complex experimental systems than binary interaction assays.